Role of the NMDA receptor subunit in the expression of the discriminative stimulus effect induced by ketamine

European Journal of Pharmacology

Volumn 423, Issue 1, 2001, Pages 41-46

  Narita, Minoru ^a   Yoshizawa, Kazumi ^a   Nomura, Mutsuko ^a   Aoki, Kazue ^a   Suzuki, Tsutomu ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Drug discrimination; Ifenprodil; Ketamine; NMDA receptor

Indexed keywords

1,3 DI 2 TOLYGUANIDINE; 3 (2 CARBOXYPIPERAZINE 4 YL)PROPYL 1 PHOSPHONIC ACID; DEXTROMETHORPHAN; DIZOCILPINE; GUANIDINE DERIVATIVE; IFENPRODIL; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE; RECEPTOR SUBUNIT; SIGMA OPIATE RECEPTOR; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATION LEARNING; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG DISCRIMINATION; DRUG EFFECT; LEARNING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; REINFORCEMENT; TASK PERFORMANCE;

ANIMALS; DEXTROMETHORPHAN; DISCRIMINATION LEARNING; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; GUANIDINES; KETAMINE; LIGANDS; MALE; PHENCYCLIDINE; PIPERAZINES; PIPERIDINES; PROTEIN SUBUNITS; RATS; RATS, INBRED F344; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, SIGMA;

EID: 0035967999     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)01089-5     Document Type: Article

References (34)

1. The NMDA antagonist model for schizophrenia: Promise and pitfalls
2. Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1/NR2A and NR1/NR2B receptors expressed in Xenopus oocytes
3. Perception of drug effects
4. Pharmacological specificity of the discriminative stimulus properties of 2-amino-4,5-(1,2-cyclohexyl)-7-pjosphonoheptanoic acid (NPC 12626), a competitive N-methyl-D-aspartate receptor antagonist
5. Interactions between glutamatergic and monoaminergic systems within the basal ganglia: Implications for schizophrenia and Parkinson's disease
6. Excitatory amino acid receptors in the vertebrate central nervous system
7. Effects of atypical antipsychotic agents on social behavior in rodents
8. Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors
9. Modulation of NMDA and dopaminergic neurotransmissions by sigma ligands: Possible implications for the treatment of psychotic disorders
10. Pharmacologic effects of CI-581, a new dissociative anesthetic, in man
11. The N-methyl-D-Asparatate antagonists phencyclidine, ketamine, dizocilpine as both behavioral and anatomical models of the dementias
12. Taking apart NMDA receptors
13. Dizocilpine-like discriminative stimulus effects of low-affinity uncompetitive NMDA antagonists
14. Phencyclidine and σ opiate receptors in brain: Biochemical and autoradiographical differentiation
15. Stereospecific effects of ketamine on dopamine efflux and uptake in the rat nucleus accumbens
16. Opioid- and phencyclidine-like discriminative effects of ditolylguanidine, a selective sigma ligand
17. Recent advances in the phencyclidine model of schizophrenia
18. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: Psychotomimetic, perceptual, cognitive, and neuroendocrine responses
19. Molecular diversity of the NMDA receptor channel
20. A simplified method of evaluating dose-effect experiments
21. Study of a new schizophrenomimetic drug, Sernyl
22. NMDA receptor function and human cognition: The effects of ketamine in healthy subjects
23. Neural mechanisms of ketamine-induced anesthesia
24. The excitatory amino acid receptors: Their classes, pharmacology, and distinct properties in the function of the central nervous system
25. Heteromeric NMDA receptors: Molecular and functional distinction of subtypes
26. Structure and function of the NMDA receptor channel
27. Effects of ketamine on sensory perception: Evidence for a role of N-methyl-D-aspartate receptors
28. Organization of N-methyl-D-Asparatate glutamate receptor gene expression in the basal ganglia of the rat
29. 1-antagonists and opioids: A drug discrimination study
30. Distinct distributions of five N-methyl-D-Asparatate receptor channel subunit mRNAs in the forebrain
31. 1,3-Di(2-[5-3H]tolyl)guanidine: A selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs
32. Drug discrimination based on the competitive N-methyl-D-aspartate antagonist, NPC 12626
33. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: Selectivity and mechanisms at recombinant heteromeric receptors
34. Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain